Jefferson’s Bruce Boman, M.D., Ph.D., Elected President of Hereditary Colorectal Cancer Group
Bruce Boman, M.D., Ph.D, has been elected president of the Collaborative Group of the Americas on Inherited Colorectal Cancer
for the term 2003-2004.
Dr. Boman is professor of medicine and of immunology and microbiology and director of the Division of Genetic and Preventive
Medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia. He directs the program for Hereditary
Cancer and the Gastrointestinal Cancer Program at Jefferson’s Kimmel Cancer Center. His research interests include the hereditary
risk for and the molecular etiology of colorectal cancer.
Established in 1995, the Collaborative Group of the Americas on Inherited Colorectal Cancer aims to improve understanding
of inherited colorectal cancer and the clinical management of affected families through education, linkage to clinical trials,
the integration of molecular and clinical research and the development of genetic registries.
Dr. Boman came to Jefferson in 1998 from Creighton University and the University of Nebraska Medical Center in Omaha, where
he was director for Cancer Research and Hereditary Tumors at the Storz Cancer Institute. Dr. Boman was the founding director
of the Creighton University Cancer Center, chairman of oncology and associate professor from 1987 to1995. He was assistant
professor in several departments at the University of Texas and M.D. Anderson Cancer Center in Houston from 1984 to 1987.
From 1982 to1984, he held a National Institutes of Health Research Fellowship at the National Cancer Institute in the Biochemical
and Molecular Epidemiology Section in the Laboratory of Human Carcinogenesis.
He received a medical degree from the University of Minnesota Medical School in 1976, a Ph.D. from the Mayo Clinic in Rochester,
Minn., in 1982, and a master of science in Public Health from the University of Minnesota in 1973.
Thomas Jefferson University Hospital’s Hereditary Cancer Program provides genetic counseling, risk assessment, genetic testing,
management and screening services for patients with inherited cancer.
For more information, call 1-800-JEFF-NOW.
Media Only Contact:Steven BenowitzThomas Jefferson University Hospital
Phone: 215-955-6300
Published: 3-23-2004